Genome & Company (KOSDAQ: 314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST

Genome & Company Revenue

Genome & Company had revenue of 11.63B KRW in the quarter ending June 30, 2024, with 213.08% growth. This brings the company's revenue in the last twelve months to 23.92B, up 59.64% year-over-year. In the year 2023, Genome & Company had annual revenue of 14.30B with 1.50% growth.

Revenue (ttm)
23.92B
Revenue Growth
+59.64%
P/S Ratio
3.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
90.28B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.30B211.39M1.50%
Dec 31, 202214.08B13.63B3,021.27%
Dec 31, 2021451.25M300.66M199.67%
Dec 31, 2020150.58M104.75M228.54%
Dec 31, 201945.83M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition